Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicentre Open-label Study on Allogeneic Stem Cell Transplantation From Unrelated, Cord-blood and Family Haploidentical Donors in Patients With Active Acute Leukemia

NCT01814488 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.

NCT NCT01814488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01814488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicentre Open-label Study on Allogeneic Stem Cell Transplantation From Unrelated, Cord-blood and Family Haploidentical Donors in Patients With Active Acute Leukemia
Lead sponsor
Gruppo Italiano Trapianto di Midollo Osseo
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
June 30, 2017
Enrollment
101 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia